Effect of deferasirox + erythropoietin vs erythropoietin on erythroid response in Low/Int-1-risk MDS patients: Results of the phase II KALLISTO trial
Gattermann, Norbert, Coll, Rosa, Jacobasch, Lutz, Allameddine, Allameddine, Azmon, Amin, DeBonnett, Laurie, Bruederle, Andreas, Jin, JieLanguage:
english
Journal:
European Journal of Haematology
DOI:
10.1111/ejh.13096
Date:
May, 2018
File:
PDF, 769 KB
english, 2018